M1 Kliniken AG (XETRA:M12) — Market Cap & Net Worth
Market Cap & Net Worth: M1 Kliniken AG (M12)
M1 Kliniken AG (XETRA:M12) has a market capitalization of $300.08 Million (€256.67 Million) as of May 2, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #14962 globally and #1464 in its home market, demonstrating a 3.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying M1 Kliniken AG's stock price €17.40 by its total outstanding shares 18778246 (18.78 Million). Analyse how efficiently does M1 Kliniken AG generate cash to see how efficiently the company converts income to cash.
M1 Kliniken AG Market Cap History: 2015 to 2026
M1 Kliniken AG's market capitalization history from 2015 to 2026. Data shows growth from $101.55 Million to $382.00 Million (13.54% CAGR).
M1 Kliniken AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how M1 Kliniken AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.07x
M1 Kliniken AG's market cap is 1.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
22.75x
M1 Kliniken AG's market cap is 22.75 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $101.55 Million | $34.93 Million | $6.63 Million | 2.91x | 15.32x |
| 2016 | $208.58 Million | $35.95 Million | $5.01 Million | 5.80x | 41.65x |
| 2017 | $269.24 Million | $47.19 Million | $5.78 Million | 5.70x | 46.60x |
| 2018 | $311.94 Million | $65.21 Million | $6.61 Million | 4.78x | 47.17x |
| 2019 | $304.94 Million | $77.22 Million | $9.73 Million | 3.95x | 31.34x |
| 2020 | $197.04 Million | $159.59 Million | $6.82 Million | 1.23x | 28.88x |
| 2021 | $159.94 Million | $314.61 Million | $8.91 Million | 0.51x | 17.96x |
| 2022 | $193.20 Million | $285.29 Million | $4.32 Million | 0.68x | 44.75x |
| 2023 | $238.84 Million | $316.32 Million | $10.27 Million | 0.76x | 23.25x |
| 2024 | $364.43 Million | $339.18 Million | $16.02 Million | 1.07x | 22.75x |
Competitor Companies of M12 by Market Capitalization
Companies near M1 Kliniken AG in the global market cap rankings as of May 2, 2026.
Key companies related to M1 Kliniken AG by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #246 globally with a market cap of $99.71 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #441 globally with a market cap of $59.14 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #570 globally with a market cap of $45.94 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1111 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #246 | McKesson Corporation | NYSE:MCK | $99.71 Billion | $814.02 |
| #441 | Cencora Inc. | NYSE:COR | $59.14 Billion | $304.00 |
| #570 | Cardinal Health Inc | NYSE:CAH | $45.94 Billion | $195.24 |
| #1111 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
M1 Kliniken AG Historical Marketcap From 2015 to 2026
Between 2015 and today, M1 Kliniken AG's market cap moved from $101.55 Million to $ 382.00 Million, with a yearly change of 13.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €382.00 Million | -8.42% |
| 2025 | €417.12 Million | +14.46% |
| 2024 | €364.43 Million | +52.59% |
| 2023 | €238.84 Million | +23.62% |
| 2022 | €193.20 Million | +20.80% |
| 2021 | €159.94 Million | -18.83% |
| 2020 | €197.04 Million | -35.39% |
| 2019 | €304.94 Million | -2.24% |
| 2018 | €311.94 Million | +15.86% |
| 2017 | €269.24 Million | +29.08% |
| 2016 | €208.58 Million | +105.39% |
| 2015 | €101.55 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of M1 Kliniken AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $300.08 Million USD |
| MoneyControl | $300.08 Million USD |
| MarketWatch | $300.08 Million USD |
| marketcap.company | $300.08 Million USD |
| Reuters | $300.08 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About M1 Kliniken AG
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdomino… Read more